Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women

Cancer

Volumn 119, Issue 3, 2013, Pages 488-494

  Schwartz, Theresa ^a,b   Stark, Azadeh ^c,d,e   Pang, Judy ^a,b   Awuah, Baffour ^f   Kleer, Celina G ^a,b   Quayson, Solomon ^f   Kingman, Stephanie ^b   Aitpillah, Francis ^f   Abantanga, Francis ^f   Jiagge, Evelyn ^b,f   Oppong, Joseph K ^f   Osei Bonsu, Ernest ^f   Martin, Iman ^g   Yan, Xiaowei ^c   Toy, Kathy ^a   Adjei, Ernest ^f   Wicha, Max ^b   Newman, Lisa A ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d GEISINGER HEALTH SYSTEM   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f Komfo Anoyke Teaching Hospital   (Ghana)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

African ancestry; aldehyde dehydrogenase 1; breast cancer; stem cell marker; triple negative breast cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CELL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

AFRICA; ARTICLE; BREAST; BREAST CANCER; BREAST CELL; BREAST DISEASE; CANCER CLASSIFICATION; EPITHELIUM CELL; ETHNICITY; FEMALE; GHANAIAN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MAMMARY STEM CELL; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; STROMA CELL; TISSUE SECTION; TRIPLE NEGATIVE BREAST CANCER;

ADOLESCENT; ADULT; BREAST NEOPLASMS; CARCINOMA; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GHANA; HUMANS; ISOENZYMES; MAMMARY GLANDS, HUMAN; MIDDLE AGED; NEOPLASTIC STEM CELLS; PRECANCEROUS CONDITIONS; RETINAL DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84872914956     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27737     Document Type: Article

References (38)

1. Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer 2010; 116: 4926-4932.
2. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-4521.
3. Fregene A, Newman LA,. Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women? Cancer 2005; 103: 1540-1550.
4. Carey L, Winer E, Viale G, Cameron D, Gianni L,. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 2010; 7: 683-692.
5. Anders CK, Carey LA,. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer 2009; 9 Suppl 2: S73-81.
6. Ginestier C, Wicha MS,. Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res 2007; 9: 109.
7. Harmes DC, DiRenzo J,. Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses? J Mammary Gland Biol Neoplasia 2009; 14: 19-27.
8. Kunju LP, Cookingham C, Toy KA, Chen W, Sabel MS, and Keeler CG,. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Modern Pathology 2011; 24: 786-793.
9. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-567.
10. Nalwoga H, Arnes JB, Wabinga H, Akslen LA,. Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. Br J Cancer 2010; 102: 369-375.
11. American Cancer Society. Breast Cancer Facts & Figures 2009-2010. Atlanta, GA: American Cancer Society, Inc.
12. SEER Cancer Statistics Review, 1975-2006, based on November 2008 SEER data submission, posted to the SEER web site, 2009 at http://seer.cancer.gov/ csr/1975-2006/. National Cancer Institute. Accessed October 1, 2011.
13. Parise CA, Bauer KR, Caggiano V,. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol 2010; 76: 44-52.
14. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
15. Amirikia KC, Mills P, Bush J, Newman LA,. Higher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendations. Cancer 2011; 117: 2747-2753.
16. http://www.ghanaweb.com/GhanahomePage/NewsArchive/artikle.php?ID=180999. Accessed August 25, 2011.
17. Segal R,. The Black Diaspora: Five Centuries of the Black Experience Outside Africa. Gordonsvillle, VA: Farrar Straus and Giroux Publishing Company, 1995.
18. Bird PA, Hill AG, Houssami N,. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease? Ann Surg Oncol 2008; 15: 1983-1988.
19. Wicha MS, Liu S, Dontu G,. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006; 66: 1883-1890; discussion 95-96.
20. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ,. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
21. Fang D, Nguyen TK, Leishear K, et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328-9337.
22. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
23. Matsui W, Huff CA, Wang Q, et al. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103: 2332-2336.
24. O'Brien CA, Pollett A, Gallinger S, Dick JE,. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
25. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978.
26. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
27. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
28. Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF,. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev 2004; 14: 43-47.
29. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF,. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
30. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF, Wicha MS,. Stem cells in normal breast development and breast cancer. Cell Prolif 2003; 36 Suppl 1: 59-72.
31. Russo JE, Hilton J,. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res 1988; 48: 2963-2968.
32. Zhou L, Jiang Y, Yan T, et al. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res Treat 2010; 122: 795-801.
33. Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL,. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 2010; 176: 2131-2138.
34. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K,. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010; 16: 876-887.
35. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45-55.
36. Yoshioka T, Umekita Y, Ohi Y, et al. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study. Histopathology 2011; 58: 608-616.
37. Resetkova E, Reis-Filho JS, Jain RK, et al. Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 2010; 123: 97-108.
38. Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ,. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer. Cell Oncol (Dordr) 2011; 34: 3-10.